Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 158
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can a Dietary Intervention Reduce Mercury Toxicity Among Native Communities in Peru?

A state of emergency has been declared in Madre de Dios, Peru due to high levels of mercury (Hg) exposure...

S-glutathionylation reactions in mitochondrial function and disease

This project was an invited review that is currently under minor revision at Frontiers Cellular and Developmental...

Open Insulin

A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

Backer Badge Funded